Zymeworks
$13.22
24H
Market Cap
Volume
Supply
Price Chart
About Zymeworks - ZYME
Zymeworks Inc. is a biopharmaceutical company that focuses on the discovery, development, and commercialization of next-generation multifunctional biotherapeutics, initially for the treatment of cancer. They are known for their proprietary platforms which can develop bispecific antibodies and other protein-based therapeutics.
What are Zymeworks's core values and mission statement?
Zymeworks Inc. is a biopharmaceutical company that focuses on the discovery, development, and commercialization of next-generation multifunctional biotherapeutics. Their core values and mission emphasize leveraging their proprietary technology platforms to create innovative therapies designed to improve patients' lives who are suffering from complex diseases.
Who founded Zymeworks and when?
Zymeworks Inc. was founded by Ali Tehrani, Anthony Fejes, and Nick Bedford in 2003.
Who leads Zymeworks?
The CEO leads Zymeworks Inc.; however, for the most current information on the company's leadership, please refer to their official website or latest corporate announcements.
Where is Zymeworks located, and what is its base country?
Zymeworks Inc. is headquartered in Vancouver, British Columbia, Canada. Its base country is Canada.
On which exchanges is Zymeworks traded?
Zymeworks Inc. is traded on the New York Stock Exchange (NYSE) under the ticker symbol "ZYME" and on the Toronto Stock Exchange (TSX) under the same ticker symbol.
Historical data
Zymeworks (ZYME) Price Live Data
The live price of Zymeworks (ZYME) is $13.22, with a trading volume of 277,201 in the last 24 hours. Wrapstocks updates the ZYME price in real-time. Zymeworks is up 2.96% in the last 24 hours. The company has a live market cap of $939,246,656.00 and a supply of 71,047,402 ZYME stocks.
Zymeworks (ZYME) is traded on NASDAQ Stock Exchange, and currently, the market is closed; trading will be resumed in 14 hours and 22 minutes.
